News

Survivorship care synonymous with palliative care


 

References

Individual differences in inflammatory response and fatigue may be caused by differences in genetic variations in the expression of proinflammatory genes, setting the stage for inflammation and fatigue after cancer treatment, and suggesting the use of anti-inflammatory medication as potential treatments for fatigue, Dr. Bower explained.


Pages

Recommended Reading

Rolapitant curbs chemo-induced nausea and vomiting
MDedge Hematology and Oncology
FDA approves new antiemetic drug combo
MDedge Hematology and Oncology
Cancer community turns focus to ‘value’
MDedge Hematology and Oncology
Patient and provider concordance on symptoms during the oncology outpatient clinic visit
MDedge Hematology and Oncology
Delivering on the promise of cancer biomarkers in the clinic
MDedge Hematology and Oncology
Purified pollen extract for hot flashes did not inhibit tamoxifen’s efficacy
MDedge Hematology and Oncology
Patient-reported outcomes drive palliative care
MDedge Hematology and Oncology
ROR score aids prognosis after 5 years on tamoxifen
MDedge Hematology and Oncology
Automated support eases hospice patient, caregiver burden
MDedge Hematology and Oncology
‘Chemo brain’ may have targetable causes
MDedge Hematology and Oncology